President’s Cancer Panel shared on LinkedIn:
“Thank you to everyone who joined us last Thursday for a robust discussion on the potential role of GLP-1 drugs to help reduce obesity-related cancer risk.
We’re now looking forward to our next meeting on October 26.
This meeting will explore the link between dietary patterns and cancer risk, as well as opportunities to apply this evidence to help strengthen cancer prevention strategies in the U.S.
Discussion at this meeting will help guide our next steps and recommendations to the President in a future report. This virtual meeting is open to the public.
For more information and to register.”
You can also read:
GLP-1 and Cancer: What Research Shows About Cancer Risk and Prevention
